{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T18:38:06Z","timestamp":1776796686492,"version":"3.51.2"},"reference-count":18,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["215663\/Z\/19\/Z"],"award-info":[{"award-number":["215663\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosglobalpublichealth.org"],"crossmark-restriction":false},"short-container-title":["PLOS Glob Public Health"],"abstract":"<jats:p>Oral cholera vaccination (OCV) is one of strategies to help control cholera with two doses recommended as initial vaccination and booster doses recommended 3\u20135 years later to prevent future outbreaks. There is no actual recommendation on the number of doses required during booster vaccination. An OCV campaign conducted in Mogode-Cameroon provided an opportunity to determine if revaccination four years after would induce a booster response. 350 people living in Mogode-Cameroon, who received 0, 1 or 2 doses of OCV four years earlier, were stratified into age groups,\u2009&lt;\u20095, 5\u201314, and &gt;14 and randomized into two arms. Arm A received a single dose and Arm B received two doses 14 days apart. We aimed to determine if people who had received OCV four years earlier responded with a booster immune response compared to those not vaccinated. Serum samples were collected at baseline and at multiple time points after vaccination to measure vibriocidal antibody titers. For Arm A, vibriocidal GMT significantly increased nine days after the first dose with a response rate of 61\u201370%; however, early vibriocidal response (day 4\u20136) was rare (22%) and were similar in those who had received vaccine four years earlier and those who did not. Ogawa, but not Inaba, vibriocidal responses were higher on day 9 for those who had been vaccinated earlier, but vibriocidal titers during subsequent timepoints were similar in all study arms. In Arm B, there were no early response (day 4\u20136) after the second dose. Overall, OCV induced a measurable immune response by day 9, but no evidence of a rapid booster response was detected following revaccination. Since there was no evidence that the earlier vaccination stimulated a booster response when vaccination is repeated, this suggests that persons being revaccinated should receive the two doses as was recommended initially.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Trial registration:<\/jats:bold>\n                    Pan African Clinical Trials Registry under the reference\n                    <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/PACTR202102660004195\" xlink:type=\"simple\">PACTR202102660004195<\/jats:ext-link>\n                    .\n                  <\/jats:p>","DOI":"10.1371\/journal.pgph.0004913","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T17:40:09Z","timestamp":1776793209000},"page":"e0004913","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgph.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serological responses to killed oral cholera vaccine (OCV) when given 4 years after initial receipt of OCV in Cameroon: A randomized controlled trial"],"prefix":"10.1371","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2156-1160","authenticated-orcid":true,"given":"Jerome","family":"Ateudjieu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4887-8931","authenticated-orcid":true,"given":"Ketina Hirma","family":"Tchio-Nighie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8027-7311","authenticated-orcid":true,"given":"Etienne","family":"Guenou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrel","family":"Fokou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8637-9685","authenticated-orcid":true,"given":"Collins","family":"Buh Nkum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7210-4210","authenticated-orcid":true,"given":"Landry","family":"Beyala Bita\u2019a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9119-6940","authenticated-orcid":true,"given":"Winny Dora","family":"Ateudjieu-Kenfack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1302-2076","authenticated-orcid":true,"given":"Sabine","family":"Nanfak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4006-073X","authenticated-orcid":true,"given":"Amanda K.","family":"Debes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9338-5119","authenticated-orcid":true,"given":"David A.","family":"Sack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"10333","key":"pgph.0004913.ref001","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/S0140-6736(22)00330-0","article-title":"Cholera","volume":"399","author":"S Kanungo","year":"2022","journal-title":"Lancet"},{"issue":"1","key":"pgph.0004913.ref002","article-title":"Oral killed cholera vaccines for preventing cholera","volume":"1","author":"KM Saif-Ur-Rahman","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"pgph.0004913.ref003","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S1473-3099(17)30359-6","article-title":"Protection against cholera from killed whole-cell oral cholera vaccines: a systematic review and meta-analysis","volume":"17","author":"Q Bi","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"pgph.0004913.ref004","article-title":"Protection from killed whole-cell cholera vaccines: a systematic review and meta-analysis","volume":"13","author":"H Xu","year":"2025","journal-title":"Lancet Glob Health"},{"issue":"1","key":"pgph.0004913.ref005","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/21645515.2019.1644882","article-title":"An overview of VaxchoraTM, a live attenuated oral cholera vaccine","volume":"16","author":"T Saluja","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"24","key":"pgph.0004913.ref006","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1016\/j.vaccine.2017.09.034","article-title":"Cholera vaccine: WHO position paper, August 2017 \u2013 Recommendations","volume":"36","author":"World Health Organization","year":"2018","journal-title":"Vaccine"},{"issue":"7","key":"pgph.0004913.ref007","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.vaccine.2019.12.034","article-title":"Augmented immune responses to a booster dose of oral cholera vaccine in Bangladeshi children less than 5 years of age: Revaccination after an interval of over three years of primary vaccination with a single dose of vaccine","volume":"38","author":"F Chowdhury","year":"2020","journal-title":"Vaccine"},{"issue":"5","key":"pgph.0004913.ref008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003809","article-title":"An Open Label Non-inferiority Trial Assessing Vibriocidal Response of a Killed Bivalent Oral Cholera Vaccine Regimen following a Five Year Interval in Kolkata, India","volume":"9","author":"S Kanungo","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"30","key":"pgph.0004913.ref009","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1016\/j.vaccine.2013.04.066","article-title":"Different kinetics of circulating antibody-secreting cell responses after primary and booster oral immunizations: a tool for assessing immunological memory","volume":"31","author":"S Leach","year":"2013","journal-title":"Vaccine"},{"issue":"1","key":"pgph.0004913.ref010","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12889-022-12610-5","article-title":"An innovative approach in monitoring oral cholera vaccination campaign: integration of a between-round survey","volume":"22","author":"J Ateudjieu","year":"2022","journal-title":"BMC Public Health"},{"issue":"5","key":"pgph.0004913.ref011","doi-asserted-by":"crossref","first-page":"974","DOI":"10.4269\/ajtmh.22-0462","article-title":"An Age-stratified, Randomized Immunogenicity Trial of Killed Oral Cholera Vaccine with Delayed Second Dose in Cameroon","volume":"107","author":"J Ateudjieu","year":"2022","journal-title":"Am J Trop Med Hyg"},{"key":"pgph.0004913.ref012","author":"Institut National de la Statistique (INS), ICF","year":"2020"},{"issue":"9","key":"pgph.0004913.ref013","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.4081\/jphia.2023.2450","article-title":"Innovative approach in assessing the children\u2019s immunization status when it cannot be documented","volume":"14","author":"J Ateudjieu","year":"2023","journal-title":"J Public Health Afr"},{"key":"pgph.0004913.ref014","article-title":"Correlates of Protection for Cholera","volume":"224","author":"AS Iyer","year":"2021","journal-title":"J Infect Dis"},{"issue":"1","key":"pgph.0004913.ref015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004307","article-title":"Evaluation in Cameroon of a Novel, Simplified Methodology to Assist Molecular Microbiological Analysis of V. cholerae in Resource-Limited Settings","volume":"10","author":"AK Debes","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"pgph.0004913.ref016","article-title":"Vibrio cholerae at the Intersection of Immunity and the Microbiome","volume":"4","author":"AA Weil","year":"2019","journal-title":"mSphere"},{"issue":"3","key":"pgph.0004913.ref017","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/mi.2009.8","article-title":"Regulatory mechanisms of immune responses to intestinal bacteria","volume":"2","author":"K Honda","year":"2009","journal-title":"Mucosal Immunol"},{"issue":"8","key":"pgph.0004913.ref018","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3390\/vaccines12080868","article-title":"Intestinal Microbiota and Its Effect on Vaccine-Induced Immune Amplification and Tolerance","volume":"12","author":"Y Liu","year":"2024","journal-title":"Vaccines"}],"container-title":["PLOS Global Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0004913","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T17:40:15Z","timestamp":1776793215000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgph.0004913"}},"subtitle":[],"editor":[{"given":"Espoir Bwenge","family":"Malembaka","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgph.0004913","relation":{},"ISSN":["2767-3375"],"issn-type":[{"value":"2767-3375","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]}}}